Leef Brands (LEEEF) Depreciation & Amortization (CF) (2025 - 2026)
Leef Brands' (LEEEF) quarterly Depreciation & Amortization (CF) came in at $568141.0 in Q1 2026, up 6.15% year-on-year from $535237.0 in Q1 2025, and up 6.15% quarter-over-quarter from $535237.0 in Q1 2025.
Leef Brands (LEEEF) Depreciation & Amortization (CF) (2025 - 2026) Analysis & Trends
Leef Brands has disclosed Depreciation & Amortization (CF) across 2 years of filings, most recently posting $568141.0 for Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $568141.0, up 6.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (changed N/A YoY), and the FY2025 annual result was $2.3 million, up 21.44% from the prior year.
- Depreciation & Amortization (CF) came in at $568141.0 for Q1 2026 at Leef Brands, up from $535237.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $568141.0 in Q1 2026 to a low of $535237.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 21.95 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 22.68 Mn |
| 10 | Leef Brands | - | - | 4.62 Mn | 568,141.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 568,141.00 |
| Mar 31, 2026 | 568,141.00 |
| Mar 31, 2025 | 535,237.00 |
| Mar 31, 2025 | 535,237.00 |